Evaluation of meropenem doses prescribed in an adult intensive care unit at a large hospital in Serra Gaúcha

Objective: To evaluate the conformity of dose and/or posology of meropenem prescribed in the setting of kidney impairment, otherwise to evaluate the microbiological profile of the germs isolated in those patients. In addition, to measure the extra costs of non-adjusted prescriptions. Method: This wo...

Full description

Bibliographic Details
Main Authors: Fernando BOARO, Ramone A. BERTUSSI
Format: Article
Language:English
Published: Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2022-12-01
Series:Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
Online Access:https://rbfhss.org.br/sbrafh/article/view/873
_version_ 1797978379321868288
author Fernando BOARO
Ramone A. BERTUSSI
author_facet Fernando BOARO
Ramone A. BERTUSSI
author_sort Fernando BOARO
collection DOAJ
description Objective: To evaluate the conformity of dose and/or posology of meropenem prescribed in the setting of kidney impairment, otherwise to evaluate the microbiological profile of the germs isolated in those patients. In addition, to measure the extra costs of non-adjusted prescriptions. Method: This work is a Drug Utilization Review. Were included charts of adult patients, of both sex, that had meropenem prescribed between 01/01/2021 and 06/30/2021, while admitted in the ICU regimen, in a large hospital in Serra Gaúcha. For dose analysis, UpToDate was used as guideline, prescriptions from patients on renal replacement therapy, as well as prescriptions from patients who did not have a creatinine result in the 24 hours prior to the prescription of meropenem, were excluded. Results: A total of 2044 prescriptions were evaluated, of which 667 were excluded because they did not meet the inclusion criteria. Of the 1377 prescriptions included, 1003 were considered adequate (73%) and 374 inadequate (27%). Of the doses considered inadequate, 54 were by underdose (14%) and 320 by overdose (86 %). The extra cost measured was US$1.835,21, equivalent to 993 vials of 500 mg. Microbiologically, there was a higher incidence of Gram-negatives: 81% (383/473). Of these, 54% resistant to meropenem (208/383), 5% (20/383) presumed sensitive, 3% (11/383) intrinsically resistant, and 38% (144/383) sensitive in vitro. Conclusion: The findings support the promotion of the service provided by the clinical pharmacist and stewardship programs, both for the promotion of health in intensive care and for the preservation of the financial health of a philanthropic institution.
first_indexed 2024-04-11T05:22:03Z
format Article
id doaj.art-b6918c06786748d8a31548519bd472e4
institution Directory Open Access Journal
issn 2179-5924
2316-7750
language English
last_indexed 2024-04-11T05:22:03Z
publishDate 2022-12-01
publisher Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
record_format Article
series Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
spelling doaj.art-b6918c06786748d8a31548519bd472e42022-12-23T19:41:53ZengSociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdeRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde2179-59242316-77502022-12-0113487387310.30968/rbfhss.2022.134.08731256Evaluation of meropenem doses prescribed in an adult intensive care unit at a large hospital in Serra GaúchaFernando BOAROhttps://orcid.org/0000-0002-8943-4694Ramone A. BERTUSSIhttps://orcid.org/0000-0002-7151-9729Objective: To evaluate the conformity of dose and/or posology of meropenem prescribed in the setting of kidney impairment, otherwise to evaluate the microbiological profile of the germs isolated in those patients. In addition, to measure the extra costs of non-adjusted prescriptions. Method: This work is a Drug Utilization Review. Were included charts of adult patients, of both sex, that had meropenem prescribed between 01/01/2021 and 06/30/2021, while admitted in the ICU regimen, in a large hospital in Serra Gaúcha. For dose analysis, UpToDate was used as guideline, prescriptions from patients on renal replacement therapy, as well as prescriptions from patients who did not have a creatinine result in the 24 hours prior to the prescription of meropenem, were excluded. Results: A total of 2044 prescriptions were evaluated, of which 667 were excluded because they did not meet the inclusion criteria. Of the 1377 prescriptions included, 1003 were considered adequate (73%) and 374 inadequate (27%). Of the doses considered inadequate, 54 were by underdose (14%) and 320 by overdose (86 %). The extra cost measured was US$1.835,21, equivalent to 993 vials of 500 mg. Microbiologically, there was a higher incidence of Gram-negatives: 81% (383/473). Of these, 54% resistant to meropenem (208/383), 5% (20/383) presumed sensitive, 3% (11/383) intrinsically resistant, and 38% (144/383) sensitive in vitro. Conclusion: The findings support the promotion of the service provided by the clinical pharmacist and stewardship programs, both for the promotion of health in intensive care and for the preservation of the financial health of a philanthropic institution.https://rbfhss.org.br/sbrafh/article/view/873
spellingShingle Fernando BOARO
Ramone A. BERTUSSI
Evaluation of meropenem doses prescribed in an adult intensive care unit at a large hospital in Serra Gaúcha
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
title Evaluation of meropenem doses prescribed in an adult intensive care unit at a large hospital in Serra Gaúcha
title_full Evaluation of meropenem doses prescribed in an adult intensive care unit at a large hospital in Serra Gaúcha
title_fullStr Evaluation of meropenem doses prescribed in an adult intensive care unit at a large hospital in Serra Gaúcha
title_full_unstemmed Evaluation of meropenem doses prescribed in an adult intensive care unit at a large hospital in Serra Gaúcha
title_short Evaluation of meropenem doses prescribed in an adult intensive care unit at a large hospital in Serra Gaúcha
title_sort evaluation of meropenem doses prescribed in an adult intensive care unit at a large hospital in serra gaucha
url https://rbfhss.org.br/sbrafh/article/view/873
work_keys_str_mv AT fernandoboaro evaluationofmeropenemdosesprescribedinanadultintensivecareunitatalargehospitalinserragaucha
AT ramoneabertussi evaluationofmeropenemdosesprescribedinanadultintensivecareunitatalargehospitalinserragaucha